← Back to Patent Explorer
US3917830A Expired / Lapsed US ⏱️ 0.0 years remaining

Steroidal anaesthetic composition for intraveneous injection

Assignee: Glaxo Laboratories Ltd
•
Filing: 1972-06-15
•
Granted: 1975-11-04
•
Expires: 1992-06-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition for use by injection as an anaesthetic comprising 3 Alpha -hydroxy 5 Alpha - pregnane - 11,20 dione in solution in an inert organic liquid medium. The composition may be in the form of a solution which also contains water, a non-aqueous solution or an emulsion or microemulsion. The emulsions and microemulsions are preferably of the oil-in-water type. Water-miscible substances which may be used as or in the liquid medium include polyhydroxy alcohols and water-soluble esters and amides. Other substances which may be used as the liquid medium include oils, long chain alcohols and esters, and fatty acid esters.

Inventors

  • 👤 Derek Roger Pearce
  • 👤 Benjamin Davis
  • 👤 Paul Connor

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 06:01
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/57; B; B82; B82Y; B82Y5/00

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 101 words
A COMPOSITION ADAPTED FOR USE IN MEDICINE BY INTRAVENOUS INJECTION AS AN ANAESTHETIC COMPRISING 3A-HYDROXY-5APREGNANE-11,20-DIONE IN SOLUTION IN AN INERT LIQUID INJECTION MEDIUM CONSISTING ESSENTIALLY OF A SOLUTION OF WATER IN AN ORGANIC LIQUID SELECTED FROM THE GROUP CONSISTING OF A POLYHYDRIC ALCOHOL HAVING 2 OR 3 HYDROXY GROUPS AND 1-6 CARBON ATOMS AND A WATER SOLUTION ESTER OF AN A-HYDROXY CARBOXYLIC ACID AND AN ALKANOL HAVING 1-6 CARBON ATOMS IN WHICH THE ORGANIC LIQUID CONSTITUTES MORE THAN 50% OF THE TOTAL INJECTION MEDIUM, SAID COMPOSITION BEING IN UNIT DOSAGE FORM, EACH DOSAGE CONTAINING 10 TO 300 MG OF THE 3A-HYDROXY-5A-PREGNANE-11,20-DIONE.
Claim 2
Dependent Claim 101 words
A COMPOSITION ADAPTED FOR USE IN MEDICINE BY INTRAVENOUS INJECTION AS AN ANAESTHETIC COMPRISING 3A-HYDROXY-5APREGNANE-11,20-DIONE IN SOLUTION IN AN INERT LIQUID INJECTION MEDIUM CONSISTING ESSENTIALLY OF A SOLUTION OF WATER IN AN ORGANIC LIQUID SELECTED FROM THE GROUP CONSISTING OF A POLYHYDRIC ALCOHOL HAVING 2 OR 3 HYDROXY GROUPS AND 1-6 CARBON ATOMS AND A WATER SOLUTION ESTER OF AN A-HYDROXY CARBOXYLIC ACID AND AN ALKANOL HAVING 1-6 CARBON ATOMS IN WHICH THE ORGANIC LIQUID CONSTITUTES MORE THAN 50% OF THE TOTAL INJECTION MEDIUM, SAID COMPOSITION BEING IN UNIT DOSAGE FORM, EACH DOSAGE CONTAINING 10 TO 300 MG OF THE 3A-HYDROXY-5A-PREGNANE-11,20-DIONE.
Claim 3
Dependent Claim 19 words
A composition as claimed in claim 1 wherein the liquid injection medium comprises propylene glycol, glycerol or glycerol formal.
Claim 4
Dependent Claim 22 words
A composition as claimed in claim 1 wherein 3 Alpha -hydroxy-5 Alpha -pregnane-11,20-dione is present in an amount of 0.1-4% by weight.
Claim 5
Dependent Claim 20 words
A method of inducing anaesthesia which method comprises intravenously administering to a subject a composition as claimed in claim 1.

References Cited (Backward Citations)

US3714352A Cited
US3781435A Cited
US3816624A Cited
US3763195A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-11-03 1979-05-05 1979-11-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-11-03 1983-05-05 1983-11-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-11-03 1987-05-05 1987-11-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag